Optimal dose of a thiazide diuretic. 1976

S Carney, and A I Gillies, and T Morgan

In essential hypertension, 25 mg and 100 mg of chlorthalidone per day reduced blood pressure to a similar extent. The larger amount (100 mg per day of chlorthalidone) caused a greater reduction in extracellular volume and a larger rise in plasma renin activity and serum uric acid levels. Hypokalaemia was common with 100 mg per day of chlorthalidone, but was rarely seen in patients who took 25 mg per day, and neither dose caused total body potassium depletion. In the management of hypertension, 25 mg of chlorthalidone is the preferred dose as it produces most of the antihypertensive effects with only minor biochemical changes.

UI MeSH Term Description Entries
D006973 Hypertension Persistently high systemic arterial BLOOD PRESSURE. Based on multiple readings (BLOOD PRESSURE DETERMINATION), hypertension is currently defined as when SYSTOLIC PRESSURE is consistently greater than 140 mm Hg or when DIASTOLIC PRESSURE is consistently 90 mm Hg or more. Blood Pressure, High,Blood Pressures, High,High Blood Pressure,High Blood Pressures
D007008 Hypokalemia Abnormally low potassium concentration in the blood. It may result from potassium loss by renal secretion or by the gastrointestinal route, as by vomiting or diarrhea. It may be manifested clinically by neuromuscular disorders ranging from weakness to paralysis, by electrocardiographic abnormalities (depression of the T wave and elevation of the U wave), by renal disease, and by gastrointestinal disorders. (Dorland, 27th ed) Hypopotassemia,Hypokalemias,Hypopotassemias
D002752 Chlorthalidone A benzenesulfonamide-phthalimidine that tautomerizes to a BENZOPHENONES form. It is considered a thiazide-like diuretic. Chlorphthalidolone,Phthalamudine,Chlortalidone,Hygroton,Oxodoline,Thalitone
D002986 Clinical Trials as Topic Works about pre-planned studies of the safety, efficacy, or optimum dosage schedule (if appropriate) of one or more diagnostic, therapeutic, or prophylactic drugs, devices, or techniques selected according to predetermined criteria of eligibility and observed for predefined evidence of favorable and unfavorable effects. This concept includes clinical trials conducted both in the U.S. and in other countries. Clinical Trial as Topic
D006801 Humans Members of the species Homo sapiens. Homo sapiens,Man (Taxonomy),Human,Man, Modern,Modern Man

Related Publications

S Carney, and A I Gillies, and T Morgan
September 1994, BMJ (Clinical research ed.),
S Carney, and A I Gillies, and T Morgan
September 1994, BMJ (Clinical research ed.),
S Carney, and A I Gillies, and T Morgan
May 2013, Vnitrni lekarstvi,
S Carney, and A I Gillies, and T Morgan
July 1994, BMJ (Clinical research ed.),
S Carney, and A I Gillies, and T Morgan
June 2012, Canadian family physician Medecin de famille canadien,
S Carney, and A I Gillies, and T Morgan
November 1966, The Journal of pharmacy and pharmacology,
S Carney, and A I Gillies, and T Morgan
September 1965, Clinique (Paris, France),
S Carney, and A I Gillies, and T Morgan
January 2018, Canadian journal of kidney health and disease,
S Carney, and A I Gillies, and T Morgan
January 2005, Blood pressure,
S Carney, and A I Gillies, and T Morgan
April 1985, Archives of dermatology,
Copied contents to your clipboard!